Navarro examines the benefits of currency tradiing. Vaino features Novadel (NVD)

Listen Now:

Peter Navarro reads the introduction to his new book The Coming China Wars. The book is available on Amazon.com and in fine bookstores everywhere.

Listen Now:

Navarro remains a short term bull. Vaino highlights Exelixis (EXEL)

Listen Now:

Navarro looks at the decoupling of the U.S. economy and stock market. Vaino looks again at HEPH

Listen Now:

Vaino shorts ImClone. Navarro handicaps an October correction.

Listen Now:

Navarro explains why the markets are up but technical analysis is losing and why oil prices are soft. Vaino offers up a biotech short.

Listen Now:

Navarro explains why Sept. is the cruelest market month. Vaino disputes the notion that "defensive stocks" are defensive and highlights Ligand Pharmaceuticals.

Listen Now:

Navarro offers the Bull vs. Bear scorecard. Vaino highlights a sweet Swiss biotech SRA.

Listen Now:

Navarro looks at how the bond king Bill Gross has gone so wrong. Vaino highlights a homeland security macroplay in biotech -- HEPH

Listen Now:

Navarro sees a short squeeze driving the latest rally. Vaino features a hot biotech nanocap.

Listen Now:

Navarro highlights the worst foreign policy gambit in U.S. history and its market implications. Vaino features a hot ethanol stock.

Listen Now:

Navarro assesses current market conditions. Vaino comes up with a hot Canadian biotech.

Listen Now:

Navarro issues a cash call for a fun summer. Vaino highlights two biotech kids fighting in the sand box -- TRCA and INSM

Listen Now:

Navarro turns short term bullish. Vaino comes up with a shorting opportunity. Davio preaches the gospel of maximum pain.

Listen Now:

Navarro looks at the prospect of 50 basis point rate hike. Vaino highlights a fallen biotech angel. Davio provides a hedge fund microcosm of a macro market.

Listen Now:

Navarro contrasts the advice of George Soros and Art Laffer. Vaino highlights a white hot biotech stock. Davio explains the new Fed conundrum.

Listen Now:

Navarro advises he Fed Chairman to zip his lip. Vaino highlights a hot biotech stock EPIX. Davio recommends a butterfly options strategy to play this market.

Listen Now:

Navarro illustrates why it's a Trader Joe's market. Vaino argues for a short sell on Sangamo Biosciences. Davio warns of liquidity trap.

Listen Now:

Navarro and Davio handicap the duration of the latest market bounce. Vaino looks at hot pick Amylin Pharmaceuticals.

Listen Now:

Navarro looks at the top which has been put into the market and warns of dead cat bounces. Davio notes the return of a bull market in volatility. Vaino highlights LCBM in the biotech corner.

Listen Now:

Navarro looks at a possible top in the market. Davio explains reflation. Vaino features ISIS pharmaceuticals.

Listen Now:

Navarro looks at the headline risk and upcoming Fed rate hike action, Davio is bullish on SPX while waiting for the reversal, and Vaino explains the mysteries of DSCO.

Listen Now:

Davio does a beautiful analysis of bullish and bearish market sectors. The biotech corner spotlights Discovery Labs (DSCO), and Navarro looks at the Bernanke bounce.

Listen Now:

Navarro reflects on the recent visit of the Chinese president and explains why the GDP number on Friday is HUGE. Vaino shorts Neurocrine. Davio explains why market tops are processes and not moments.

Listen Now:

Navarro provides a very interesting comparison of GDP growth rates prior to the 2001 recession and now. Davio explains why the yield curve is likely signaling slowdown, despite the contrary majority view. Vaino showcases Celgene and its star drug Revlimid.

Listen Now:

Navarro compares the 2006 economy and stock market to 1994 versus 2000 to parse the bull versus bear question. Davio looks at the state of the stock market indices versus oil, gold, and bond prices. Vaino takes a really cool look at Spherix (SPEX) and its sweet but risky play.

Listen Now:

Navarro explains why revaluing the Chinese yuan is not the cure politicians make it out to be -- and the big risks involved. Vaino illustrates that biotech is a better play than Big Pharma and pans a couple of stocks. STAA and IMAX are the featured portfolio picks. The week's market movers are reviewed. (Davio is on vacation)

Listen Now:

Navarro reviews the coming week's market movers, including the Fed meeting on Tuesday. In the portfolio section, he introduces a new China telecom play with good technicals, XING. Davio's contribution, meanwhile, is required reading for anyone who thinks that ETFs are a great way to hold a sector or hedge sector risk. Vaino deals nicely with what might have been some egg on his face. After you see the discussion of VRX, you will see what I mean.

Listen Now:

Keene is one of the best radio analysts on the air. This interview looks at everything from current market conditions to the state of MBA education.

Listen Now:

Davio illustrates why the housing market may be in for a technical bounce. Vaino comes up with a really interesting story about the economics of ethanol and a company named Diversa. Navarro previews next week's market movers and previews some new stocks in the portfolio.

Listen Now:

Navarro cites two very rare events as indicators of market weakness. Davio provides a treatise on the relatonship between commodity prices and stock and bond market movements. Vaino highlights a new biotech stock VRX. The weekly market movers are highlighted. Stock picks and pan!

Listen Now:

Navarro reviews the upcoming macro calendar and reveals a few new stock picks and pans. Davio takes a hard look at the consumer and issues a bearish call for the retail sector. New contributor Andrew Vaino goes long on ELN, TRCA and INSM.

Listen Now:

Navarro likens the current market to a poker game in a hurricane. Davio features some astonishing quotes from Paul Volcker and Robert Rubin and analyzes the dollar chart. The macroeconomic calendar promises a hot and heavy volatile week. Hot new stock picks....

Listen Now:

Navarro looks at Ben Bernanke's upcoming testimony before Congress. Davio analyzes charts for gold, commodities, the S&P500 and the Nasdaq

Listen Now:

Navarro discusses the "February Effect," Davio explains why the Russell 2000 may be in a parabolic fade and what it means for the market, and stock picks and pans features a special section on plastic surgery stocks.

Listen Now:

In the Big Picture, Navarro tries to sort out a bullish January Effect from a longer term bear trap. Davio looks at global reflation. A very big macroeconomic calender is previewed and three new stocks are added to the portfolio.

Listen Now:

Navarro calls a market top. Davio looks at the three major drivers of mediocre performance. A slew of earnings reports and Friday's GDP report are tagged as the big market movers of the week. Navarrp calls for shorts on the retail, finanancial services and banking sectors.

Listen Now:

Navarro explains the Fed's current conundrum and previews the week's economic calender. Davio explains the importance of housing in the GDP equation. MSFT and RIMM are analyzed.

Listen Now:

Navarro assesses whether the fast start for the stock market in 2006 is a harbinger of a new bull market. Davio looks at the stats on bullish investor sentiment and the times that has actually yielded a bull market. Navarro previews the economic calendar, focusing on the trade report and the PPI.

Listen Now: